1. Yokoyama, W. M. (2013). Natural killer cells. In W. Paul (Ed.), Fundamental immunology (pp. 395–430). Philadelphia: Lippincott, Williams &Wilkins.
2. Sullivan, K. E., Delaat, C. A., Douglas, S. D., & Filipovich, A. H. (1998). Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives. Pediatric Research, 44, 465–468.
3. Caligiuri, M. A. (2008). Human natural killer cells. Blood, 112, 461–469.
4. Freud, A. G., Mundy-Bosse, B. L., Yu, J., & Caligiuri, M. A. (2017). The broad spectrum of human natural killer cell diversity. Immunity, 47, 820–833.
5. Fehniger, T. A., Shah, M. H., Turner, M. J., VanDeusen, J. B., Whitman, S. P., Cooper, M. A., et al. (1999). Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: Implications for the innate immune response. Journal of Immunology, 162, 4511–4520.